THULASIRAMAN RAVICHANDRAN, MD
Diagnostic Neuroimaging (Psychiatry & Neurology) Physician in MILWAUKEE, Wisconsin. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
THULASIRAMAN RAVICHANDRAN, MD filed 3,126 Medicare Part D claims in 2023 as a Diagnostic Neuroimaging (Psychiatry & Neurology) Physician in MILWAUKEE, Wisconsin, prescribing 58% generic.
- 3K
- Part D claims, 2023
- 58%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
THULASIRAMAN RAVICHANDRAN, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
3,126 Top 11% higher than 89% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
THULASIRAMAN RAVICHANDRAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about THULASIRAMAN RAVICHANDRAN, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Wisconsin
How Diagnostic Neuroimaging (Psychiatry & Neurology) Physician compares to other specialties among Wisconsin providers
Diagnostic Neuroimaging (Psychiatry & Neurology) Physician share within Wisconsin
Diagnostic Neuroimaging (Psychiatry & Neurology) Physician is one of the more visible NUCC categories in Wisconsin
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Diagnostic Neuroimaging (Psychiatry & Neurology) Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Diagnostic Neuroimaging (Psychiatry & Neurology) Physician ABMS/AOA estimate
Est. board-certified rate (Diagnostic Neuroimaging (Psychiatry & Neurology) Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Diagnostic Neuroimaging (Psychiatry & Neurology) Physician US NPIs
Specialty board-certified rate — Diagnostic Neuroimaging (Psychiatry & Neurology) Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
THULASIRAMAN RAVICHANDRAN, MD appears in the CMS NPPES registry as a Diagnostic Neuroimaging (Psychiatry & Neurology) Physician provider holding MD credentials at 2025 W OKLAHOMA AVE, MILWAUKEE, WI, 53215, with a listed phone of (414) 382-8960. NPI 1861447906 was issued on 05/24/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RAVICHANDRAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 3,126 prescription claims written by this provider, covering 253 Medicare beneficiaries and totaling roughly $3.0 million in drug spend, split 42% brand-name and 58% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Diagnostic Neuroimaging (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 30 enrolled providers across 16 states and an average of 1,149 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1861447906 |
|---|---|
| Specialty | Diagnostic Neuroimaging (Psychiatry & Neurology) Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/24/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm THULASIRAMAN RAVICHANDRAN, MD's current license status, disciplinary history, and board certifications with the Wisconsin Department of Safety and Professional Services in Wisconsin before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where THULASIRAMAN RAVICHANDRAN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for THULASIRAMAN RAVICHANDRAN, MD. Source: openpaymentsdata.cms.gov.
Total received
$8.1K
Largest payer
LivaNova USA, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
42% brand-name claims vs 58% generic, on 3,126 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 4,845
- Total Day Supply
- 140,190
- Brand vs Generic
- 42% brand / 58% generic
- Brand Drug Cost
- $2.7M
- Generic Drug Cost
- $307K
Patient Demographics
- Average Patient Age
- 64.2 years
- Avg HCC Risk Score
- 1.85
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 122, 65-74: 82, 75-84: 36, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What THULASIRAMAN RAVICHANDRAN, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Pregabalin
Pregabalin
280 claims
- Briviact
Briviact
214 claims
- Rytary
Rytary
160 claims
- Lacosamide
Lacosamide
156 claims
- Duloxetine Hcl
Duloxetine Hcl
143 claims
- Xcopri
Xcopri
113 claims
- Cyclobenzaprine Hcl 106
Cyclobenzaprine Hcl
106 claims
- Aptiom 103
Aptiom
103 claims
| Drug | Claims |
|---|---|
| Pregabalin | 280 |
| Briviact Brivaracetam | 214 |
| Rytary Carbidopa/Levodopa | 160 |
| Lacosamide | 156 |
| Duloxetine Hcl | 143 |
| Xcopri Cenobamate | 113 |
| Cyclobenzaprine Hcl | 106 |
| Aptiom Eslicarbazepine Acetate | 103 |
| Clopidogrel Clopidogrel Bisulfate | 98 |
| Oxtellar Xr Oxcarbazepine | 91 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Diagnostic Neuroimaging (Psychiatry & Neurology) Physician Overview
How THULASIRAMAN RAVICHANDRAN, MD fits within the Diagnostic Neuroimaging (Psychiatry & Neurology) Physician landscape nationally.
THULASIRAMAN RAVICHANDRAN, MD's 3,126 claims are above the specialty average of 1,149.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Wisconsin
Frequently Asked Questions
What is THULASIRAMAN RAVICHANDRAN, MD's specialty? ▼
How much does THULASIRAMAN RAVICHANDRAN, MD prescribe under Medicare Part D? ▼
Where is THULASIRAMAN RAVICHANDRAN, MD located? ▼
What is THULASIRAMAN RAVICHANDRAN, MD's NPI number? ▼
Does THULASIRAMAN RAVICHANDRAN, MD prescribe more brand-name or generic drugs? ▼
How many Diagnostic Neuroimaging (Psychiatry & Neurology) Physician providers are there in the US? ▼
What drugs does THULASIRAMAN RAVICHANDRAN, MD prescribe most often? ▼
Does THULASIRAMAN RAVICHANDRAN, MD accept Medicare? ▼
How can I verify THULASIRAMAN RAVICHANDRAN, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology